Viewing Study NCT00005859


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2026-02-24 @ 8:25 AM
Study NCT ID: NCT00005859
Status: COMPLETED
Last Update Posted: 2018-06-26
First Post: 2000-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module